Detalhe da pesquisa
1.
Multiplex Detection of Clinically Relevant Mutations in Liquid Biopsies of Cancer Patients Using a Hybridization-Based Platform.
Clin Chem
; 67(3): 554-563, 2021 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33439966
2.
Development of a gene panel for next-generation sequencing of clinically relevant mutations in cell-free DNA from cancer patients.
Br J Cancer
; 116(6): 802-810, 2017 Mar 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-28170370
3.
Vaccine antibodies against a synthetic epidermal growth factor variant enhance the antitumor effects of inhibitors targeting the MAPK/ERK and PI3K/Akt pathways.
Transl Oncol
; 40: 101878, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38183801
4.
Overcoming MET-mediated resistance in oncogene-driven NSCLC.
iScience
; 26(7): 107006, 2023 Jul 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-37534190
5.
Effect of Osimertinib on CTCs and ctDNA in EGFR Mutant Non-Small Cell Lung Cancer Patients: The Prognostic Relevance of Liquid Biopsy.
Cancers (Basel)
; 14(6)2022 Mar 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-35326725
6.
RNA-Based Multiplexing Assay for Routine Testing of Fusion and Splicing Variants in Cytological Samples of NSCLC Patients.
Diagnostics (Basel)
; 11(1)2020 Dec 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-33374879
7.
Evolution and Clinical Impact of EGFR Mutations in Circulating Free DNA in the BELIEF Trial.
J Thorac Oncol
; 15(3): 416-425, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31812754
8.
Prospective detection of mutations in cerebrospinal fluid, pleural effusion, and ascites of advanced cancer patients to guide treatment decisions.
Mol Oncol
; 13(12): 2633-2645, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31529604
9.
Prospective analysis of liquid biopsies of advanced non-small cell lung cancer patients after progression to targeted therapies using GeneReader NGS platform.
Transl Cancer Res
; 8(Suppl 1): S3-S15, 2019 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-35117060
10.
An update on liquid biopsy analysis for diagnostic and monitoring applications in non-small cell lung cancer.
Expert Rev Mol Diagn
; 18(1): 35-45, 2018 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29172773
11.
Early evolution of BRAFV600 status in the blood of melanoma patients correlates with clinical outcome and identifies patients refractory to therapy.
Melanoma Res
; 28(3): 195-203, 2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29481492
12.
Liquid Biopsy in Non-Small Cell Lung Cancer.
Front Med (Lausanne)
; 3: 69, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-28066769
13.
cfDNA analysis from blood in melanoma.
Ann Transl Med
; 3(20): 309, 2015 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-26697469
14.
BRAF mutation analysis in circulating free tumor DNA of melanoma patients treated with BRAF inhibitors.
Melanoma Res
; 25(6): 486-95, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26366702
15.
Association of EGFR L858R Mutation in Circulating Free DNA With Survival in the EURTAC Trial.
JAMA Oncol
; 1(2): 149-57, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-26181014